Gene · 55902
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of novel brain permeable human ACSS2 inhibitors for blocking breast cancer brain metastatic growth. | bioRxiv | 2023 | 38187734 | PubTator, text mining | PubMed |
| Metabolomic Signatures of Treatment Response in Bladder Cancer. | Int J Mol Sci | 2023 | 38139377 | PubTator, text mining | PubMed |
| An Overview on Lipid Droplets Accumulation as Novel Target for Acute Myeloid Leukemia Therapy. | Biomedicines | 2023 | 38137407 | PubTator, text mining | PubMed |
| A Rare Variant in MDH2 (rs111879470) Is Associated with Predisposition to Recurrent Breast Cancer in an Extended High-Risk Pedigree. | Cancers (Basel) | 2023 | 38136396 | PubTator, text mining | PubMed |
| Targeting the Adipose Tissue-Liver-Gut Microbiota Crosstalk to Cure MASLD. | Biology (Basel) | 2023 | 38132297 | PubTator, text mining | PubMed |
| PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition. | Cell Rep Med | 2023 | 38118413 | PubTator, text mining | PubMed |
| CXCL10-based gene cluster model serves as a potential diagnostic biomarker for premature ovarian failure. | PeerJ | 2023 | 38107572 | PubTator, text mining | PubMed |
| Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. | Front Immunol | 2023 | 38106410 | PubTator, text mining | PubMed |
| Therapeutic protein PAK restrains the progression of triple negative breast cancer through degrading SREBP-1 mRNA. | Breast Cancer Res | 2023 | 38082285 | PubTator, text mining | PubMed |
| Comparative gut proteomics study revealing adaptive physiology of Eurasian spruce bark beetle, Ips typographus (Coleoptera: Scolytinae). | Front Plant Sci | 2023 | 38078109 | PubTator, text mining | PubMed |
| Functioning and mechanisms of PTMs in renal diseases. | Front Pharmacol | 2023 | 38074159 | PubTator, text mining | PubMed |
| Differential cardiomyocyte transcriptomic remodeling during in vitro Trypanosoma cruzi infection using laboratory strains provides implications on pathogenic host responses. | Trop Med Health | 2023 | 38062533 | PubTator, text mining | PubMed |
| Genomics of Preaxostyla Flagellates Illuminates the Path Towards the Loss of Mitochondria. | PLoS Genet | 2023 | 38060519 | PubTator, text mining | PubMed |
| Shared and distinct pathways and networks genetically linked to coronary artery disease between human and mouse. | Elife | 2023 | 38060277 | PubTator, text mining | PubMed |
| Targeting dysregulated lipid metabolism in the tumor microenvironment. | Arch Pharm Res | 2023 | 38060103 | PubTator, text mining | PubMed |
| ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. | J Clin Invest | 2023 | 38051585 | PubTator, text mining | PubMed |
| Potential therapies targeting nuclear metabolic regulation in cancer. | MedComm (2020) | 2023 | 38034101 | PubTator, text mining | PubMed |
| Prognostic value analysis of cholesterol and cholesterol homeostasis related genes in breast cancer by Mendelian randomization and multi-omics machine learning. | Front Oncol | 2023 | 38023262 | PubTator, text mining | PubMed |
| The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade. | Front Cell Dev Biol | 2023 | 38020920 | PubTator, text mining | PubMed |
| Bidirectional interplay between metabolism and epigenetics in hematopoietic stem cells and leukemia. | EMBO J | 2023 | 38010205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55902/papers?page=12